SCHEMBL20042696

SCHEMBL20042696

Cc1nc2c(c(N3CCC3)n1)CN(C(=O)c1ccc(C#N)c(F)c1)C2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 11/20 0.45
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
P2RX7 Q99572 1/20 0.41
GRM5 P41594 1/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALDH1A1 P00352 1/20 0.38
MAPK1 P28482 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20042754 0.92 MEN1 (0.41) KDM1ACYP11B1CYP11B2MEN1KMT2A
SCHEMBL20042666 0.89 KMT2A (0.46) MEN1KMT2AP2RX7GRM5
SCHEMBL20042733 0.88 MEN1 (0.41) MEN1KMT2AP2RX7KDM4EHPGD
SCHEMBL20042903 0.88 MEN1 (0.42) MEN1KMT2AP2RX7KDM4EHPGD
SCHEMBL20042823 0.88 P2RX7 (0.45) MEN1KMT2AP2RX7HPGDTSHR
SCHEMBL20042821 0.86 MEN1 (0.41) MEN1KMT2AP2RX7KDM4EHPGD
SCHEMBL20042792 0.86 TACR3 (0.46) MEN1KMT2AP2RX7HPGD
SCHEMBL20042836 0.86 P2RX7 (0.43) MEN1KMT2AP2RX7HPGDTSHR
SCHEMBL20042698 0.85 MEN1 (0.43) MEN1KMT2AP2RX7KDM4EHPGD
SCHEMBL20042728 0.85 MEN1 (0.42) MEN1KMT2AALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed